Related Experiment Video
Updated: Feb 6, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Glucose oxidase mediated targeted cancer-starving therapy by biotinylated self-assembled vesicles
Soumik Dinda1, Saheli Sarkar, Prasanta Kumar Das
1Department of Biological Chemistry, Indian Association for the Cultivation of Science, Kolkata - 700 032, India. bcpkd@iacs.res.in.
Abstract:
Herein, we demonstrate glucose oxidase (GOx) mediated targeted cancer-starving therapy by self-assembled vesicle of trimesic acid based biotinylated amphiphile (TMB). The TMB vesicles entrapped GOx and selectively killed cancer cells (HeLa, B16F10), with ∼6-fold higher efficiency compared to non-cancer cells (CHO, NIH3T3), by blocking the energy supply to tumors through the oxidation of intracellular glucose.
Insights
This study introduces a novel cancer therapy using glucose oxidase (GOx) within self-assembled vesicles. These targeted vesicles starve cancer cells by blocking their energy supply, showing significantly higher efficiency against cancer cells.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Cancer cells exhibit altered metabolism, relying heavily on glucose.
- Targeted therapies aim to selectively eliminate cancer cells while sparing healthy ones.
- Nanocarriers offer potential for drug delivery and therapeutic agent encapsulation.
Purpose of the Study:
- To develop a targeted cancer-starving therapy using glucose oxidase (GOx).
- To investigate the efficacy of self-assembled trimesic acid based biotinylated amphiphile (TMB) vesicles for cancer treatment.
- To evaluate the selective killing of cancer cells by GOx-loaded TMB vesicles.
Main Methods:
- Self-assembly of trimesic acid based biotinylated amphiphile (TMB) into vesicles.
- Encapsulation of glucose oxidase (GOx) enzyme within TMB vesicles.
- In vitro evaluation of cell viability using cancer cell lines (HeLa, B16F10) and non-cancer cell lines (CHO, NIH3T3).
Main Results:
- TMB vesicles successfully entrapped GOx.
- GOx-loaded TMB vesicles demonstrated selective toxicity towards cancer cells.
- Cancer cells showed approximately 6-fold higher sensitivity to the therapy compared to non-cancer cells.
- The mechanism involves blocking tumor energy supply via intracellular glucose oxidation.
Conclusions:
- Self-assembled TMB vesicles loaded with GOx represent a promising strategy for targeted cancer-starving therapy.
- This approach offers enhanced selectivity and efficiency in eliminating cancer cells.
- The findings highlight the potential of nanovesicle-based enzyme delivery for cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Receptor-mediated Endocytosis
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

